News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
226 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (23348)
Month
January (2794)
February (3040)
March (3567)
April (3109)
May (3537)
June (3472)
July (2691)
August (3172)
September (3382)
October (3298)
November (3733)
December (2588)
Day
1 (201)
2 (230)
3 (246)
4 (177)
7 (255)
8 (244)
9 (226)
10 (211)
11 (142)
13 (1)
14 (230)
15 (257)
16 (153)
17 (152)
18 (97)
21 (137)
22 (152)
23 (132)
28 (195)
29 (152)
30 (143)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
7
8
9
10
11
13
14
15
16
17
18
21
22
23
28
29
30
Business
IntriCon Corporation Reports 2011 Third-Quarter Results
November 9, 2011
·
1 min read
Policy
Curis, Inc. Announces FDA Acceptance and Priority Review of NDA for Vismodegib as Treatment for Advanced Basal Cell Carcinoma
November 9, 2011
·
1 min read
Deals
S1P1 Lead Compounds, Assets Generated by EPIX Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Target Rationale for S1P1 Agonists Explained.
November 9, 2011
·
1 min read
Drug Development
NephroGenex Reaches Agreement with the FDA on a Subpart H Phase 3 Program for Pyridorin(TM)
November 9, 2011
·
1 min read
Alkermes plc’s Corporate Presentation to be Webcast at Lazard Capital Markets 8th Annual Healthcare Conference
November 9, 2011
·
1 min read
BioMidwest
Spectranetics Corporation to Present at the Citi Small/Mid Cap Conference on November 16
November 9, 2011
·
1 min read
Business
Euthymics Bioscience, Inc. Appoints Dr. Randall Marshall, Leader in the Psychiatric Field, as Executive Director, Medical Affairs
November 9, 2011
·
1 min read
Genetown
AIU Ph.D Asks: Could Invasive Species Become the Next Biological Weapon?
November 9, 2011
·
1 min read
Drug Development
Sinovac Biotech Ltd. Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
November 9, 2011
·
5 min read
BioMidwest
Colorado BioScience Association Launches Internship Program With Support of 11 Area Employers and Universities
November 9, 2011
·
1 min read
Previous
7 of 23
Next
